The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study evaluating the effect of IMNN-001 on second-look laparoscopy (SLL) when administered in combination with bevacizumab (BEV) and neoadjuvant chemotherapy (NACT) in patients newly diagnosed with advanced epithelial ovarian cancer (EOC).
 
Amir A. Jazaeri
Stock and Other Ownership Interests - Avenge Bio; Greenfire Bio
Honoraria - Gerson Lehrman Group; Guidepoint Global
Consulting or Advisory Role - Adicet Bio; Iovance Biotherapeutics; Macrogenics; Theolytics
Research Funding - Aravive (Inst); AstraZeneca (Inst); Avenge Bio (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); immatics (Inst); Imunon (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Stryker
 
Rachel N. Grisham
Employment - Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - AstraZeneca; Corcept Therapeutics; GlaxoSmithKline; Intellisphere; Myriad Genetics; Signatera; SpringWorks Therapeutics; Verastem
Research Funding - Bayer (Inst); Context Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); SpringWorks Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; Cardinal Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem
 
Stephanie Gaillard
Consulting or Advisory Role - Immunogen; Merck; Verastem
Research Funding - AstraZeneca (Inst); Blueprint Pharmaceutic (Inst); Clovis Oncology (Inst); Compugen (Inst); Genentech/Roche (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst); Tempest Therapeutics (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - United States Patent Nos 10,258,604 & 10,905,659, licensed by Duke University to Sermonix (Inst)
 
Jeffrey Andrew How
Research Funding - MacroGenics; Merck
 
Sebastien Hazard
Employment - Bicycle Therapeutics; GlaxoSmithKline; Imunon; TESARO
Leadership - Imunon
Stock and Other Ownership Interests - Bicycle Therapeutics; GlaxoSmithKline; Immunogen; Imunon; TESARO
 
Lauren Musso
Employment - Imunon
Stock and Other Ownership Interests - Imunon
 
Chrisann Kyi
Honoraria - OncLive/MJH Life Sciences; Total Health
Consulting or Advisory Role - Scenic Biotech
Research Funding - Acrivon Therapeutics; Bristol Myers Squibb,; Centessa Pharmaceuticals; Eisai; Gritstone Bio; Incyte; Merus
Travel, Accommodations, Expenses - Gritstone Bio